Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer

被引：3
|
作者：
Bilgin, Burak [1 ]
Sendur, Mehmet A. N. [1 ]
Hizal, Mutlu [1 ]
Akinci, Muhammed Bulent [1 ]
Dede, Didem Sener [1 ]
Yalcin, Bulent [1 ]
机构：
[1] Yildirim Beyazit Univ, Fac Med, Dept Med Oncol, TR-06800 Ankara, Turkey
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 22期
关键词：
abiraterone; androgen deprivation therapy; docetaxel; prostate cancer;
D O I：
10.2217/fon-2017-0270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1911 / 1913
页数：3
相关论文
共 50 条
  • [1] Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ...
    Barata, Pedro C.
    Sartor, A. Oliver
    [J]. CANCER, 2019, 125 (11) : 1777 - 1788
  • [2] Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!
    Messina, Carlo
    Messina, Marco
    Boccardo, Francesco
    [J]. EUROPEAN UROLOGY, 2018, 73 (01) : 147 - 148
  • [3] Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients
    Pathak, Surabhi
    Thekkekara, Romy
    Yadav, Udit
    Ahmed, Ahmed Tarig
    Yim, Barbara
    Lad, Thomas E.
    Mullane, Michael
    Batra, Kumar Kunnal
    Aronow, Wilbert S.
    Psutka, Sarah P.
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E380 - E387
  • [4] Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic hormone-sensitive prostate cancer in Indian population
    Gupta, Alok
    Hussain, Shaik Maheboob
    Sonthwal, Neha
    Chaturvedi, Harit
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (02) : 389 - 392
  • [5] Docetaxel or abiraterone in combination with androgen deprivation therapy for metastatic prostate cancer
    Hammerer, P.
    Manka, L.
    [J]. UROLOGE, 2019, 58 (10): : 1185 - 1197
  • [6] Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis
    Ciccarese, Chiara
    Iacovelli, Roberto
    Sternberg, Cora N.
    Gillessen, Silke
    Tortora, Giampaolo
    Fizazi, Karim
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 173 : 276 - 284
  • [7] Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic castration-naive prostate cancer in South Asian population.
    Sonthwal, Neha
    Hussain, Shaik Maheboob
    Arya, Devavrat
    Batra, Sandeep
    Chaturvedi, Harit Kumar
    Gupta, Alok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Fizazi, Karim
    NamPhuong Tran
    Fein, Luis
    Matsubara, Nobuaki
    Rodriguez-Antolin, Alfredo
    Alekseev, Boris Y.
    Ozguroglu, Mustafa
    Ye, Dingwei
    Feyerabend, Susan
    Protheroe, Andrew
    De Porre, Peter
    Kheoh, Thian
    Park, Youn C.
    Todd, Mary B.
    Chi, Kim N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 352 - 360
  • [9] Re: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2018, 199 (01): : 26 - 28
  • [10] Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer
    Struss, Werner J.
    Black, Peter C.
    [J]. UROLOGY, 2017, 109 : 1 - 2
12345